Capricor Therapeutics Signs Exclusive Worldwide License ...

It has signed an exclusive, worldwide licensing agreement with Johns Hopkins University (JHU) to include engineered exosomes for vaccines and therapeutics.

Capricor Therapeutics Signs Exclusive Worldwide License

Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology ...

8-K - Capricor Therapeutics

Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome. Platform Technology ...

Capricor Therapeutics Announces Intent to File Biologics License ...

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases,

Capricor Therapeutics Signs Exclusive Worldwide License ... - Reddit

Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology Portfolio - April ...

Capricor Therapeutics Signs Exclusive Worldwide License ...

Capricor Therapeutics announced that it has signed an exclusive, worldwide licensing agreement with Johns Hopkins University to include engineered exosomes ...

Exclusive License Agreement, dated as of April 28, 2021, by

Exclusive License Agreement, dated as of April 28, 2021, by and between Capricor, Inc. and Johns Hopkins University from CAPRICOR THERAPEUTICS, ...

Capricor Therapeutics, Inc. Enters Into Exclusive License ... - BioSpace

... therapeutic platform in regenerative medicine. Under the terms of the agreement, Capricor has been granted an exclusive world-wide license ...

Capricor Therapeutics Signs Exclusive Worldwide License ... - Gale

Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology Portfolio.

Capricor Therapeutics Announces Intent to File Biologics

Capricor Therapeutics announces intent to file biologics license application for full approval of Deramiocel for the treatment of Duchenne muscular dystrophy ...

Press Releases :: Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology Portfolio. Mar 11 ...

Capricor Therapeutics Enters Into Exclusive License With Cedars ...

... therapeutic platform in regenerative medicine. Under the terms of the agreement, Capricor has been granted an exclusive worldwide license ...

Capricor Therapeutics Announces Intent to File Biologics License ...

Market opportunity: DMD affects approximately 1 in 3,500 male births worldwide. ... Capricor has entered into an agreement for the exclusive ...

Capricor Therapeutics Enters Into Exclusive License With Cedars ...

... therapeutic platform in regenerative medicine. Under the terms of the agreement, Capricor has been granted an exclusive world-wide license ...

CAPR - Capricor Therapeutics Inc Latest Stock News & Market ...

Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology Portfolio. Rhea-AI ...

10-K Filing - Capricor Therapeutics

... signals identified by the HOPE-2 DSMB. HOPE-2 Study Results - 12 ... The JHU Exosome License Agreement provided for the grant of an exclusive, worldwide ...

CAPRICOR THERAPEUTICS, INC. Contracts & Agreements | Justia

... Capricor Therapeutics, Inc., Capricor, Inc. and Nippon Shinyaku Co. Ltd (Filed With SEC on March 11, 2022); Exclusive License Agreement, dated as of April 28 ...

capricor | Exosome RNA

Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology Portfolio. April 30 ...

10-K - Capricor Therapeutics

The Amended Mayo Agreement provides for the grant of an exclusive, world-wide, royalty-bearing license by Mayo to the Company (with the right to sublicense) ...

Capricor Therapeutics Signs Binding Term Sheet with Nippon ...

... worldwide,” said Linda Marbán, Ph.D., Capricor's Chief Executive Officer. “With the addition of the upfront payment and equity investment ...